Details for Patent: 8,404,744
✉ Email this page to a colleague
Summary for Patent: 8,404,744
| Title: | Methods of treatment and pharmaceutical composition |
| Abstract: | The invention relates a pharmaceutical composition comprising a combination of (i) the AT 1-antagonist valsartan or a pharmaceutically acceptable salt thereof and (ii) a NEP inhibitor or a pharmaceutically acceptable salt thereof and optionally a pharmaceutically acceptable carrier and to a method for the treatment or prevention of selected conditions or diseases. |
| Inventor(s): | Ksander; Gary M (Milford, NJ), Webb; Randy L (Flemington, NJ) |
| Assignee: | Novartis AG (Basel, CH) |
| Application Number: | 13/328,769 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 8,404,744 |
|
Patent Claim Types: see list of patent claims | Composition; Compound; Dosage form; |
Drugs Protected by US Patent 8,404,744
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 8,404,744
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Austria | 370732 | ⤷ Try a Trial | |||
| Australia | 2003206738 | ⤷ Try a Trial | |||
| Brazil | 0306907 | ⤷ Try a Trial | |||
| Brazil | 122018015003 | ⤷ Try a Trial | |||
| Brazil | PI0306907 | ⤷ Try a Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
